Recruitment

Recruitment Status
Not yet recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Acute Coronary Syndrome
  • Atheroma; Heart
  • Atherosclerosis
  • Atherosclerosis Coronary Artery With Angina Pectoris
  • Atherosclerosis, Coronary
  • Emotional Stress
  • Hematopoiesis
  • Inflammation
Design
Observational Model: CohortTime Perspective: Prospective

Participation Requirements

Age
Between 20 years and 75 years
Gender
Both males and females

Description

Thirty two patients with multivessel coronary artery disease (including both stable angina and acute coronary syndrome), who have at least one severe obstructive lesion (>70% diameter stenosis) that is considered suitable for percutaneous coronary intervention (PCI), will be included in the study. S...

Thirty two patients with multivessel coronary artery disease (including both stable angina and acute coronary syndrome), who have at least one severe obstructive lesion (>70% diameter stenosis) that is considered suitable for percutaneous coronary intervention (PCI), will be included in the study. Structural/biochemical characteristics of coronary culprit plaque (with or without mild to moderate stenotic non-culprit plaque) will be assessed comprehensively using OCT-FLIM dual modal intravascular imaging. After coronary revascularization with PCI, subjects will undergo serial 18F-FDG-PET/CT molecular imaging at baseline admission and 6-month follow-up to measure PET signal activities at target tissues including amygdala, carotid artery, aorta, bone marrow, and spleen. Correlation between OCT-FLIM parameters and baseline PET signals will be assessed to provide insight into the mechanistic linkage between multi-system metabolic activities and coronary plaque instability. Serial PET/CT imaging after 6 month will enable estimation of natural course of multi-system PET signal activities according to different levels of coronary plaque instability.

Tracking Information

NCT #
NCT04853511
Collaborators
Not Provided
Investigators
Principal Investigator: Jin Won Kim, MD, PhD Korea University Guro Hospital Study Director: Dong Oh Kang, MD, PhD Korea University Guro Hospital Study Director: Sun Won Kim, MD, PhD Korea University Study Director: Hongki Yoo, PhD Korea Advanced Institute of Science and Technology